AGIOS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.49 USD | -0.57% |
|
+6.64% | +41.40% |
Chart calendar Agios Pharmaceuticals, Inc.
1fc0e2609626f9a42ed5be944b19.u9GBZfOhApe6ubWvfV0vHT7H-gKI5q7L5JZv1gVcUe4.9un5N6TmbdTc08bKBGR1alu313H6iPiOsds1lDI4IononPEjy-Zh8e3ogQ~0c138bb63f4872e0cd19fa76253f82d3
Upcoming events on Agios Pharmaceuticals, Inc.
Past events on Agios Pharmaceuticals, Inc.
| 12/03/2024 14:00 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 19:10 | TD Cowen Health Care Conference |
| 15/02/2024 13:00 | Q4 2023 Earnings Call |
| 15/02/2024 12:00 | Q4 2023 Earnings Release |
| 10/01/2024 15:30 | JPMorgan Healthcare Conference |
| 03/01/2024 13:00 | ENERGIZE Phase 3 Study Results Call |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract No 3850 |
| 11/12/2023 15:00 | American Society of Hematology Meeting |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No 3692 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No 3222 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No 2492 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No 2485 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No 2515 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract No 3691 |
| 11/12/2023 01:00 | American Society of Hematology Meeting - Abstract No 561 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Abstract No 1085 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Abstract No 1071 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Abstract No 1854 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Abstract No 2376 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Abstract No 2365 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 118 116 1.53% | 203 199 2.08% | 0,00 0,57 - | 14,2 13,9 2.5% | 26,8 27,7 -3.23% | 42,2 |
|
EBITDA Million USD | Released Forecast Spread | -418 -428 2.25% | -306 -308 0.74% | -369 -362 -2.02% | -380 -382 0.4% | -385 -378 -1.88% | -337 |
|
EBIT Million USD | Released Forecast Spread | -426 -426 -0.17% | -316 -317 0.18% | -378 -362 -4.41% | -389 -386 -0.66% | -391 -384 -1.86% | -379 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -411 -416 1% | -327 -321 -1.85% | -357 -360 1.03% | -232 -341 31.98% | -352 -348 -1.05% | -284 |
|
Net income Million USD | Released Forecast Spread | -411 -416 1.13% | -327 -322 -1.52% | 1 605 1 608 -0.23% | -232 -348 33.38% | -352 -353 0.29% | -318 |
|
EPS USD | Released Forecast Spread | -6,86 -6,94 1.19% | -4,74 -4,65 -1.93% | 26,6 25,5 4.06% | -4,23 -6,29 32.75% | -6,33 -6,26 -1.15% | -5,48 |
| Announcement Date | 13/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,56 - | 0,83 2,71 -69.32% | 5,58 2,86 95.12% | 3,52 5,24 -32.87% | 4,31 4,53 -4.95% | 5,61 5,23 7.17% | 6,71 6,46 3.86% | 7,40 7,53 -1.69% | 7,10 7,92 -10.36% | 8,37 | 9,51 | 11,1 | 12,7 | 38,2 |
|
EBITDA Million USD | Released Forecast Spread | -88,8 -99,0 10.28% | -91,9 -93,0 1.19% | -105 -102 -2.82% | -100 | -99,0 | -100 | 100 | |||||||
|
EBIT Million USD | Released Forecast Spread | -105 -93,0 -12.72% | -101 -102 0.61% | -97,6 -101 3.44% | -91,1 -100 8.92% | -99,2 -95,9 -3.36% | -90,6 -98,6 8.14% | -93,7 -95,0 1.36% | -101 -101 -0.08% | -106 -99,1 -7.24% | -99,4 | -101 | -99,2 | -79,7 | -76,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -98,6 -93,0 -6.02% | -94,8 -102 6.9% | -91,8 -98,1 6.39% | -81,7 -95,4 14.34% | 36,5 -67,9 153.79% | -81,0 -94,2 13.96% | -83,8 -88,3 5.1% | -91,3 -92,1 0.82% | -95,9 -93,5 -2.63% | -91,2 | -92,7 | -58,5 | -27,2 | -67,4 |
|
Net income Million USD | Released Forecast Spread | -94,6 -92,3 -2.52% | -94,8 -100 5.31% | -91,8 -98,6 6.93% | -81,7 -95,6 14.51% | 36,5 -72,0 150.71% | -81,0 -95,8 15.45% | -83,8 -88,3 5.09% | -91,3 -95,0 3.9% | -95,9 -93,9 -2.19% | -94,2 | -94,7 | -69,3 | -51,0 | -67,4 |
|
EPS USD | Released Forecast Spread | -1,74 -1,69 -3.13% | -1,74 -1,81 4.01% | -1,68 -1,75 3.79% | -1,49 -1,76 15.55% | 0,67 -1,37 148.94% | -1,47 -1,70 13.58% | -1,51 -1,56 3.27% | -1,64 -1,70 3.71% | -1,72 -1,65 -4.38% | -1,65 | -1,66 | -1,24 | -0,95 | -1,17 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 15/02/24 | - | - | - | - | - |
More events
Past sector events for Agios Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AGIO Stock
- Calendar Agios Pharmaceuticals, Inc.
